Biotechnology
Digital Health/Therapeutics
TrialScreen x Castor: direct-to-patient enrollment, three months early
Discover how TrialScreen and Castor closed enrollment three months early on a fully virtual, direct-to-patient study (Travelers Diarrhea), with 96.7% ePRO engagement.